Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise)
Status:
Terminated
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if an FDA-approved drug (Gralise) can help people with
certain types of neuropathic pain without causing too many side effects.